Multiple Sclerosis Agents

Random Miscellaneous Quiz

Can you name the Multiple Sclerosis Agents?

Quiz not verified by Sporcle

How to Play
First line drugs for disease modification
Axathioprine class
Dose: 1250 mg/day PO for 3-5 days
Prednisone class
Fingolimod class
Natalizumab class
Methylprednisone class
Carbamazepine class
MOA: alkylating agent
Use: pain and paroxysmal disorders
Modafinil class
Baclofen class
IFN beta 1-a (Avonex) class
Methylphenidate class
Venlafaxine class
Dose: Oral daily (first PO MS drug)
Use: Depression. Also helps with fatigue
Dose: 1 gram/day IV for 3-5 days
Dalfampridine class
Dose: SC injection 2-3 times weekly
Tizanidine class
Second line agent for RRMS that produces reduction in progression of disabilty
SE: Seizures at higher than recommended doses (contraindicated in pts with a hx of seizure)
SE: Localized inj site reactions. Self-limited (15-20 min) acute rxn resembling a panic attack (palpitations, dyspnea, flushing) -- not an indication to stop tx
Use: For pts who do not respond to corticosteroids during acute attacks
Second line agent MOA: monoclonal Ab
Gabapentin class
Use: Depression. Also helps with pain
IFN beta 1-a (Rebif) class
MOA: Sphingosine 1-phosphate receptor modulator. Sequesters lymphocytes.
Dose: IM weekly
Tricyclic class
Alemtizumab class
First line RRMS agent injected SC daily
SE: HR reduction of 10-20 bpm, occasionally bradyarrhythmias or AV block -- screen for cardiac dz (6 hr monitoring w/ first dose). Macular edema in 1% (reversible). Check varicella
Mitoxantrone class
Dose: Oral. In extreme cases intrathecal
Use: treatment of spasticity
SE: Inj site rxn w/ high doses, flu-like s/s (responds well to naproxen), monitor liver fx, may develop neutralizing Ab, may increase depression.
MOA: Synthetic form of myelin basic PRO copolymer 1. Binds to MHC molecules. Competes w/ myelin antigens for presentation to T cells.
Daclizumab class
SE: Thyroid disorders, ITP (with fatal brain hemorrhage), infections.
SE: Risk of progressive multifocal leukoencephalopathy. Rare fatal viral (polymyxoma JC virus) reactivation infxn affecting white matter in immunosuppressed (only a risk to pts w/
Cyclophosphamide class
Second line agent: RRMS. Reduced relapses & progression of disability
Glatiramer acetate class
Use: Fatigue, cognitive impairment (long acting agent)
Excreted by kidney: contraindicated in moderate to severe renal failure
MOA: Immune modulator, exact mechanism not known.
MOA: Immunomodulator/antineoplastic
Bupropion class
Use: Fatigue
MOA: Antimetabolite and antifolate
Second line agent: RRMS, SPMS, Progressive Relapsing MS
Rituximab class
MOA: Monoclonal Ab. Shows functional improvement not just slowing of decline
MOA: Purine analog
Second line agent given IV monthy
Off line agent used in the treatment of acute attacks
Dose: SC injection every other day
IFN beta 1-b (Betaseron) class
Duloxetine class
MOA: Anti-organ rejection drug
MOA: Potassium channel blocker. Possibly increases conduction in demyelinated axons
Mycophenolate class
Dose: IV infusion every 3 months
Plasmapheresis class
Methotrexate class

Friend Scores

  Player Best Score Plays Last Played
You You haven't played this game yet.

You Might Also Like...


Created Oct 18, 2011ReportNominate
Tags:agent, multiple